Welcome to LookChem.com Sign In|Join Free

CAS

  • or

381716-33-2

Post Buying Request

381716-33-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • Factory Price API 99% D-GALACTOSE 1-[2-(2-AZIDOETHOXY)ETHOXYETHYL]-2,3,4,6-TETRA-O-ACETATE 381716-33-2 GMP Manufacturer

    Cas No: 381716-33-2

  • USD $ 0.1-0.1 / Gram

  • 1 Gram

  • 100 Metric Ton/Year

  • Xi'an Xszo Chem Co., Ltd.
  • Contact Supplier
  • [(2R,3S,4S,5R)-3,4,5-triacetyloxy-6-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]oxan-2-yl]methyl acetate

    Cas No: 381716-33-2

  • No Data

  • No Data

  • No Data

  • Chemlyte Solutions
  • Contact Supplier

381716-33-2 Usage

Description

D-GALACTOSE 1-[2-(2-AZIDOETHOXY)ETHOXYETHYL]-2,3,4,6-TETRA-O-ACETATE, also known as 2-[2-(2-Azidoethoxy)ethoxy]ethyl 2,3,4,6-Tetra-O-acetyl-D-galactopyranoside (CAS# 381716-33-2), is a stable and sensitive fluorescent probe derived from D-galactose. It is characterized by its unique chemical structure, which includes an azidoethoxyethoxyethyl group and multiple acetate groups. D-GALACTOSE 1-[2-(2-AZIDOETHOXY)ETHOXYETHYL]-2,3,4,6-TETRA-O-ACETATE is known for its ability to serve as a reactant in various chemical reactions and as a probe for biological applications.

Uses

Used in Biomedical Research:
D-GALACTOSE 1-[2-(2-AZIDOETHOXY)ETHOXYETHYL]-2,3,4,6-TETRA-O-ACETATE is used as a fluorescent probe for lysosome labeling and tracking during apoptosis. Its application in this field is due to its stable and sensitive fluorescence properties, which allow for the efficient detection and monitoring of lysosomal activity in cells undergoing programmed cell death.
Used in Pharmaceutical Development:
In the pharmaceutical industry, D-GALACTOSE 1-[2-(2-AZIDOETHOXY)ETHOXYETHYL]-2,3,4,6-TETRA-O-ACETATE is used as a reactant in the preparation of amyloid-β and tau peptide aggregation modulators. These modulators are essential in the development of therapeutic strategies for neurodegenerative diseases, such as Alzheimer's disease, where the aggregation of amyloid-β and tau proteins plays a significant role in the pathology of the condition.
Used in Chemical Synthesis:
D-GALACTOSE 1-[2-(2-AZIDOETHOXY)ETHOXYETHYL]-2,3,4,6-TETRA-O-ACETATE is also utilized as a reactant in various chemical synthesis processes. Its unique chemical structure allows for the creation of new compounds with potential applications in different industries, including pharmaceuticals, materials science, and biotechnology.

Check Digit Verification of cas no

The CAS Registry Mumber 381716-33-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,8,1,7,1 and 6 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 381716-33:
(8*3)+(7*8)+(6*1)+(5*7)+(4*1)+(3*6)+(2*3)+(1*3)=152
152 % 10 = 2
So 381716-33-2 is a valid CAS Registry Number.
InChI:InChI=1/C20H31N3O12/c1-12(24)31-11-16-17(32-13(2)25)18(33-14(3)26)19(34-15(4)27)20(35-16)30-10-9-29-8-7-28-6-5-22-23-21/h16-20H,5-11H2,1-4H3/t16-,17+,18+,19-,20?/m1/s1

381716-33-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (G0257)  2-[2-(2-Azidoethoxy)ethoxy]ethyl 2,3,4,6-Tetra-O-acetyl-D-galactopyranoside  >95.0%(N)

  • 381716-33-2

  • 1g

  • 2,450.00CNY

  • Detail
  • TCI America

  • (G0257)  2-[2-(2-Azidoethoxy)ethoxy]ethyl 2,3,4,6-Tetra-O-acetyl-D-galactopyranoside  >95.0%(N)

  • 381716-33-2

  • 5g

  • 5,800.00CNY

  • Detail

381716-33-2Downstream Products

381716-33-2Relevant articles and documents

Glycosyl spiropyrane compound and application thereof

-

Paragraph 0024-0027, (2021/09/22)

The invention discloses a glycosyl spiropyrane compound, which has a structural general formula shown in the specification, in the formula I, R is a monosaccharide group or an acetyl-protected monosaccharide group; and n is an integer from 1 to 12. The glycosyl spiropyrane compound disclosed by the invention has photochromic performance, can realize in-situ labeling of bacteria, especially pseudomonas aeruginosa, realizes light-operated 'on-off' labeling of bacteria in situ in a manner of targeting pseudomonas aeruginosa by galactose by utilizing the photochromic performance of spiropyrane, and realizes in-situ labeling of bacteria through circulating illumination of ultraviolet/visible light. And on-off detection of bacteria is realized.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 381716-33-2